Halozyme Therapeutics Inc
F:RV7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Halozyme Therapeutics Inc
F:RV7
|
US |
|
B
|
Baxter International Inc
XMUN:BTL
|
US |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
ICON PLC
NASDAQ:ICLR
|
IE |
|
H
|
HA Sustainable Infrastructure Capital Inc
F:6HA
|
US |
|
Odfjell Drilling Ltd
F:OD3
|
BM |
|
YG Plus Inc
KRX:037270
|
KR |
|
DBS Group Holdings Ltd
F:DEVL
|
SG |
|
Parks! America Inc
OTC:PRKA
|
US |
|
C
|
Credicorp Ltd
F:D8V
|
PE |
|
Fujitsu Ltd
F:FUJ1
|
JP |
|
A
|
Adiwarna Anugerah Abadi PT Tbk
IDX:NAIK
|
ID |
|
Mfe-Mediaforeurope NV
F:T0J1
|
IT |
|
Milbon Co Ltd
TSE:4919
|
JP |
|
Naigai Tec Corp
TSE:3374
|
JP |
|
GL Events SA
OTC:GLCDF
|
FR |
|
G
|
Genematrix Inc
KOSDAQ:109820
|
KR |
|
I
|
Italgas SpA
SWB:I10
|
IT |
|
A
|
APact Co Ltd
KOSDAQ:200470
|
KR |
|
Kingfisher PLC
F:KFI1
|
UK |
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
IT |
|
HeraMED Ltd
ASX:HMD
|
AU |
|
Jig-Saw Inc
TSE:3914
|
JP |
|
J
|
Japan Logistic Systems Corp
TSE:9060
|
JP |
Bankruptcy Probability
Halozyme Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Halozyme Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
13.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Halozyme Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Halozyme Therapeutics Inc has total debt of 1.9B USD. This includes both short-term (0 USD) and long-term (1.9B USD) debt.
You can find a full breakdown on its Balance Sheet.